Saša Čučnik

2.7k citations
102 papers · 1.7k indexed · h-index 23
Topics
Systemic Lupus Erythematosus Research (49 papers)Monoclonal and Polyclonal Antibodies Research (33 papers)Platelet Disorders and Treatments (18 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEBrain
Partner nations
SloveniaAustriaSweden

In The Last Decade

Saša Čučnik

100 papers receiving 1.6k citations

Peers

Saša Čučnik
Comparison fields: 5 of 109
  • Rheumatology 807
  • Immunology 353
  • Hematology 352
  • Molecular Biology 338
  • Radiology, Nuclear Medicine and Imaging 297
Replace Sophie Roux with:
Sophie Roux France
Daisuke Goto Japan
Carlos Alberto von Mühlen Brazil
Chunde Bao China
Makoto Kamachi Japan
Wang‐Dong Xu China
K Obata Japan
Yuya Kondo Japan
Mimi Høier‐Madsen Denmark
Yasushi Inoue Japan
Saša Čučnik relative to Sophie Roux France Sophie Roux's profile →
Citations per field
00.5×3.5×
Sophie Roux · 1×
Citations per year

Countries citing papers authored by Saša Čučnik

Since Specialization
Citations

This map shows the geographic impact of Saša Čučnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saša Čučnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saša Čučnik more than expected).

Fields of papers citing papers by Saša Čučnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saša Čučnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saša Čučnik. The network helps show where Saša Čučnik may publish in the future.

Co-authorship network of co-authors of Saša Čučnik

This figure shows the co-authorship network connecting the top 25 collaborators of Saša Čučnik. A scholar is included among the top collaborators of Saša Čučnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saša Čučnik. Saša Čučnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 1
3 0
4 4
5 5
6 9
7 6
8 2
9 10
10 13
11 23
12 95
13 1
14 3
15 23
16 12
17 8
18 47
19 12
20 20

About Saša Čučnik

Saša Čučnik is a scholar working on Rheumatology, Immunology and Allergy and Hematology, having authored 102 papers that have together received 1.7k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (49 papers), Monoclonal and Polyclonal Antibodies Research (33 papers) and Platelet Disorders and Treatments (18 papers). The work is most often cited by research in Rheumatology (807 citations), Hematology (352 citations) and Nephrology (141 citations). Saša Čučnik has collaborated with scholars based in Slovenia, Austria and Sweden. Frequent co-authors include Tanja Kveder, Borut Božič, Blaž Rozman, Polona Žigon, Snežna Sodin‐Šemrl, Aleš Ambrožič, Matija Tomšič, Katja Lakota, Tadej Avčin and Žiga Rotar. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026